Polymorphisms in genes involved in the estrogen pathway and mammographic density
Open Access
- 22 November 2010
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 10 (1) , 636
Abstract
Single nucleotide polymorphisms (SNPs) in genes involved in the estrogen pathway appear to be associated with breast cancer risk and possibly with mammographic density (MD), but little is known of these associations among premenopausal women. This study examines the association of 11 polymorphisms in five estrogen-related genes (estrogen receptors alpha and beta (ERα, ERβ), 17β-hydroxysteroid dehydrogenase 1 (HSD17B1), catechol-O-methyltransferase (COMT), cytochrome P450 1B1 (CYP1B1)) with premenopausal MD. Effect modification of four estrogen-related factors (parity, age at menarche, hormonal derivatives use and body mass index (BMI)) on this relation is also assessed.Keywords
This publication has 56 references indexed in Scilit:
- Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancerBreast Cancer Research, 2010
- Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal womenBreast Cancer Research, 2009
- Cytochrome P450 1B1 Val432Leu polymorphism and breast cancer risk in Nigerian women: a case control studyInfectious Agents and Cancer, 2009
- Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopeniaMetabolism, 2009
- Mammographic Density and Candidate Gene Variants: A Twins and Sisters StudyCancer Epidemiology, Biomarkers & Prevention, 2007
- Influence of Estrogen Receptor α and Progesterone Receptor Polymorphisms on the Effects of Hormone Therapy on Mammographic DensityCancer Epidemiology, Biomarkers & Prevention, 2006
- Haplotype Analysis of theHSD17B1Gene and Risk of Breast Cancer: A Comprehensive Approach to Multicenter Analyses of Prospective Cohort StudiesCancer Research, 2006
- 17β-Hydroxysteroid Dehydrogenase Type 1 Is an Independent Prognostic Marker in Breast CancerCancer Research, 2004
- An investigation of mammographic density and gene variants in healthy womenInternational Journal of Cancer, 2004
- Diversity in the mechanisms of gene regulation by estrogen receptorsBioEssays, 2002